GENECURE Wins $300,000 Federal Contract
Copyright © Targeted News Service 2022
2022-07-10
WASHINGTON, July 10 -- GENECURE, Norcross, Georgia, won a federal contract award for $300,000 from the Department of Health and Human Services National Institutes of Health, Bethesda, Maryland, for the development of replication-defective HIV as a vaccine candidate.
Contract Award Number: 75N93022C00013; ueiSAM: LFPEB7MMJCG3; NAICS Code: 54171; Product Service Code (PSC): An11; Solicitation Number: 75N93022C00013; SBA - Total Small Business Set-Aside (FAR 19.5) . . .
Karen Telphia karen.telphia@nih.gov
Contract Award Number: 75N93022C00013; ueiSAM: LFPEB7MMJCG3; NAICS Code: 54171; Product Service Code (PSC): An11; Solicitation Number: 75N93022C00013; SBA - Total Small Business Set-Aside (FAR 19.5) . . .
Targeted News Service Information Request Form
Karen Telphia karen.telphia@nih.gov
